PAVmed (PAVM) PT Raised to $8 at Maxim Group, Following Business Update
Tweet
Share
E-mailGet Alerts PAVM Hot Sheet
Price: $5.20 +9.70%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Maxim Group analyst Anthony Vendetti raised the price target on PAVmed (NASDAQ: PAVM) to $8.00 (from $5.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
